Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference
21 Novembre 2023 - 10:30PM
Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage
biotechnology company with a mission to discover, develop and
deliver potentially curative therapies that address the underlying
causes of heart disease, today announced that Faraz Ali, Chief
Executive Officer, will participate in the 35th Annual Piper
Sandler Healthcare Conference taking place in New York, NY.
Details of participation are as follows:
Fireside ChatDate: November 28,
2023Time: 6:30 AM PT / 9:30 AM ET
A webcast of the Piper Sandler event will be available by
visiting the Investors section of Tenaya’s website. A replay of the
webcast will be available on the Tenaya website for approximately
30 days following the conference.
About Tenaya TherapeuticsTenaya
Therapeutics is a clinical-stage biotechnology company committed to
a bold mission: to discover, develop and deliver potentially
curative therapies that address the underlying drivers of heart
disease. Leveraging its integrated and interrelated Gene Therapy,
Cellular Regeneration and Precision Medicine platforms and
proprietary core capabilities, the company is advancing a pipeline
of novel therapies with diverse treatment modalities for rare
genetic cardiovascular disorders and more prevalent heart
conditions. Tenaya’s most advanced candidates include TN-201, a
gene therapy for MYBPC3-associated hypertrophic cardiomyopathy
(HCM), TN-401, a gene therapy for PKP2-associated arrhythmogenic
right ventricular cardiomyopathy (ARVC), and TN-301, a small
molecule HDAC6 inhibitor being initially developed for heart
failure with preserved ejection fraction (HFpEF). Tenaya also has
multiple early-stage programs progressing through preclinical
development. For more information,
visit www.tenayatherapeutics.com.
ContactsMichelle CorralVP, Corporate
Communications and Investor RelationsIR@tenayathera.com
InvestorsJulie SeidelStern Investor
RelationsJulie.seidel@SternIR.com
Tenaya Therapeutics (NASDAQ:TNYA)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Tenaya Therapeutics (NASDAQ:TNYA)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024